Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationPlasma CellsMultiple MyelomaHematopoietic Stem Cell MobilizationTransplantation ConditioningPOEMS SyndromeTransplantation, HomologousAmyloidosisMelphalanGranulocyte Colony-Stimulating FactorAntigens, CD34LeukapheresisHematologic NeoplasmsCombined Modality TherapyBlood Component RemovalStem Cell TransplantationCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseParaproteinemiasMyeloablative AgonistsBusulfanGraft SurvivalTreatment OutcomeBone Marrow TransplantationLymphoma, Non-HodgkinHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineCord Blood Stem Cell TransplantationIfosfamideSalvage TherapyVincristineHematopoiesisStem CellsCytarabineDisease-Free SurvivalHodgkin DiseaseTransplantation ChimeraTissue DonorsRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationTime FactorsSurvival AnalysisHistocompatibility TestingHistocompatibilityInfectionLymphoma, T-CellDoxorubicinPlatelet CountBlood Cell CountTransplantation, IsogeneicPrednisoneCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteLeukemiaDexamethasoneRecombinant ProteinsVidarabineFollow-Up StudiesAntineoplastic AgentsLymphomaBone Marrow PurgingAntibodies, MonoclonalProspective StudiesBlood CellsCytomegalovirus InfectionsFatal OutcomeGraft vs Leukemia EffectFeasibility StudiesImmunophenotypingMyelodysplastic SyndromesLymphocyte DepletionT-LymphocytesAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesBone MarrowBlood Transfusion, AutologousLiver TransplantationHLA AntigensLeukocytes, MononuclearBlood DonorsFlow CytometryLeukemia, Plasma CellPrognosisHistiocytosis, Non-Langerhans-CellLivedo ReticularisOpportunistic InfectionsPrecursor Cell Lymphoblastic Leukemia-Lymphoma